21-Jan-16 LG Life Sciences will start selling Korea's first diabetes treatment Zemiglo in the global market this year. The Korean drugmaker sealed licensing partnerships with Sanofi and Stendhal in 2013, and will begin selling the new treatment in India and five countries in Central America from March 2016. [image: LG / Business Korea]

21-Jan-16 China plans to open 20 Traditional Chinese Medicine (TCM) collaboration centers overseas in 2016. The centers will be based on the various needs for TCM in different countries and will require local partners, including hospitals, research institutions and pharma companies. The international market for TCM is valued at USD50 bn. [image: Bao Kangxuan / Asianewsphoto]

19-Jan-16 Currently, there is no global standard for mHealth in clinical trials, and the use of wearable devices raise regulatory challenges as sponsors question whether regulatory agencies in Asia and globally will accept mHealth data. Of particular concern are the expectations around safety monitoring. [image: BioSpectrum]

18-Jan-16 With policy support and a local talent pool, biomedicine may be the next big thing in Taiwan as President-elect Tsai Ing-wen takes office in May. Biotech is one of the five focus industries to be cultivated by the the new government, which will also invested in the development of drugs, medical instruments and materials. [image: University of Melbourne]

14-Jan-16 Unsafe use of medication is a major issue in both developed and developing countries, causing millions of injuries and costing USD4 bn annually. 10% of patients worldwide are affected, said a WHO report. "A global concerted effort is needed to address patient medication safety... Communication has become the buzzword," said Dr. SD Gupta, President of IIHMR University in Jaipur. [image: Keval News]